Iferanserin (hydrochloride)
Iferanserin hydrochloride (S-MPEC hydrochloride) is a selective serotonin receptor antagonist with the potential to inhibit internal hemorrhoids. Iferanserin hydrochloride demonstrated efficacy and tolerability in ongoing Phase IIb clinical trials, with the ability to significantly reduce patient-reported symptoms of bleeding and pruritus[1].
Product Specifications
CAS Number
210350-29-1
Product Name Alternative
S-MPEC (hydrochloride)
UNSPSC
12352211
Target
5-HT Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/iferanserin-hydrochloride.html
Smiles
CN(CCCC1)[C@@H]1CCC2=C(C=CC=C2)NC(/C=C/C3=CC=CC=C3)=O.Cl
Molecular Formula
C23H29ClN2O
Molecular Weight
384.94
References & Citations
[1]Herold A, et al. Intra-anal Iferanserin 10 mg BID for hemorrhoid disease: a prospective, randomized, double-blind, placebo-controlled trial. Clin Ther. 2012 Feb;34 (2) :329-40.|[2]Intra-anal Iferanserin 10 mg BID for hemorrhoid disease: a prospective, randomized, double-blind, placebo-controlled trial
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
5-HT2 Receptor
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
